missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human KAZALD1 Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (87%), Rat (87%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-52859 (PA5-52859. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
This gene encodes a secreted member of the insulin growth factor-binding protein (IGFBP) superfamily. It contains an N-terminal insulin growth factor-binding domain, a central Kazal-type serine protease inhibitor and follistatin-like domain, and a C-terminal immunoglobulin-like domain. Studies of the mouse ortholog suggest that this gene product may have a function in bone development and bone regeneration.
Specifications
Specifications
| Accession Number | Q96I82 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 81621 |
| Name | Human KAZALD1 Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | bone- and odontoblast-expressed gene 1; BONO1; FKSG28; FKSG40; FLJ24094; IGFBP-related protein 10; IGFBP-rP10; Kazal type serine peptidase inhibitor domain 1; KAZALD1; kazal-type serine protease inhibitor domain-containing protein 1; novel kazal-type serine protease inhibitor domain and immunoglobulin domain containing protein; UNQ2945/PRO21184 |
| Common Name | KAZALD1 |
| Show More |